COVID‐19 and the impact on blood availability and transfusion practices in low‐ and middle‐income countries

Author:

Barnes Linda S.123ORCID,Al‐Riyami Arwa Z.4ORCID,Ipe Tina S.5ORCID,Bloch Evan M.6ORCID,Sibinga Cees Smit7ORCID,Eichbaum Quentin G.8,

Affiliation:

1. Biotherapies AABB Bethesda Maryland USA

2. Doctor of Public Health Leadership Department University of Illinois at Chicago Chicago Illinois USA

3. X‐CellSystem, Inc. Seattle Washington USA

4. Department of Hematology Sultan Qaboos University Hospital Muscat Oman

5. Department of Pathology University of Arkansas for Medical Sciences Little Rock Arkansas USA

6. Department of Pathology Johns Hopkins University School of Medicine Baltimore Maryland USA

7. International Development of Transfusion Medicine University of Groningen Zuidhorn The Netherlands

8. Vanderbilt University Medical Center Nashville Tennessee USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Reference41 articles.

1. Coronavirus disease (COVID‐19) situation reports. World Health Organization.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed 2020 Apr 28.

2. COVID-19 pandemic – an African perspective

3. The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries

4. Coronavirus Disease 2019: Coronaviruses and Blood Safety

5. Blood component utilization in COVID‐19 patients in New York City: Transfusions do not follow the curve

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3